Also be aware that in many cases with pharma launch costs are carried by the supplier either directly or indirectly by rebating or discounting wholesale pricing and further volume discounts.. Beware of any so called initial order announcements and if they are sale or return etc.
Just pointing out that it may take a few quarters before holders become aware of just what is in agreemnent and any possible returns.
After MHRA the below briefness doesn't instill confidence IMO
"Regulatory registration
The product is registered and no further registrations are required prior to sale."
If the above is correct and we haven't noticed anything apart from euro approval why has this taken so long?
.
Ann: VIRALEZE ADMENTA agreement - supplementary information, page-15
-
- There are more pages in this discussion • 79 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.7¢ |
Change
-0.003(3.00%) |
Mkt cap ! $40.48M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 9.7¢ | $111.3K | 1.115M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 43696 | 9.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 130967 | 1 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| SPL (ASX) Chart |